A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.
Clinical trial NCT05938270 · COMPLETED
Trial details
- NCT number
- NCT05938270
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-21
- Primary completion
- 2026-06-15
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.